<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="ijerph-17-05904-t006" orientation="portrait" position="float">
 <object-id pub-id-type="pii">ijerph-17-05904-t006_Table 6</object-id>
 <label>Table 6</label>
 <caption>
  <p>Development of vaccines for COVID-19 that are under clinical trials.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Vaccine</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Allocation</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Title of Study</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Location</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Clinical Trial Number</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">BCG vaccine</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Randomized</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine (BCG-CORONA)</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Multiple sites in the Netherlands</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">NCT04328441</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">SARS-CoV-2 inactivated vaccine</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Randomized</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">A Randomized, Double-Blinded, Placebo-Controlled, Phase Ⅰ/Ⅱ Clinical Trial, to Evaluate the Safety and Immunogenicity of the SARS-CoV-2 Inactivated Vaccine in Healthy Adults</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Suining County Center for Disease Control and Prevention in China</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">NCT04352608</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">mRNA-1273</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Non-Randomized</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19)</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Multiple sites in America</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">NCT04283461</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">LV-SMENP-DC vaccine and antigen-specific CTLs</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">NA</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Phase I/II Multicenter Trial of Lentiviral Minigene Vaccine (LV-SMENP) of Covid-19 Coronavirus</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong, China</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">NCT04276896</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">bacTRL-Spike vaccine</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Randomized</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">A Phase 1, Randomized, Observer-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability, and Immunogenicity of the bacTRL-Spike Oral Candidate Vaccine for the Prevention of COVID-19 in Healthy Adults</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Canadian Center for Vaccinology Dalhousie University, IWK Health Centre</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">
     <sup>a</sup> NCT04334980
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">ChAdOx1 nCoV-19 vaccine</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Randomized</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Phase 2/3 Study to Determine the Efficacy, Safety and Immunogenicity of the Candidate Coronavirus Disease (COVID-19) Vaccine ChAdOx1 nCoV-19 vaccine</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Multiple sites in United Kingdom</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">NCT04400838</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inactivated SARS-CoV-2 Vaccine</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Randomized</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A Randomized, Double-blind, Placebo-controlled, Phase Ia/IIa Trial of an Inactivated SARS-CoV-2 vaccine in Healthy People Aged 18 to 59 Years</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Multiple sites in China</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NCT04412538</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>BCG, Bacillus Calmette–Guérin; 
    <sup>a</sup> clinical trials not yet recruiting at the time of publication; data from clinical trials.gov.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
